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Abstract
Objective: To discuss about blood loss in an obstetric 
setting, the role of blood transfusion, and patient blood 
management.
Methods: Literature review.
Results: Severe anaemia with hemoglobin level less 
than 7 g/dL or late gestation (more than 34 weeks) and/
or signifi cant symptoms of anaemia, the recommendation 
is giving only single unit transfusion followed by clinical 
reassessment for further transfusion. In postpartum 
hemorrhage (PPH), massive transfusion protocols are 
commonly used description as large volume of blood 
products over a brief period to a patient with uncontrolled 
or severe hemorrhage, transfusion more than 10 RBC units 
within 24 hours, transfusion more than 4 RBC units in 1 hour 
with anticipation of continued need for blood, replacement 
of more than 50% of total blood volume by blood products 
within 3 hours. All obstetric units have a clear-cut massive 
transfusion protocol for the initial management of life-
threatening PPH, considering early transfusion therapy with 
RBCs and FFP.
Conclusions: Patient blood management aims to maintain 
hemoglobin concentration, optimize haemostasis, and 
minimize blood loss in effort to improve patient outcomes. 
Massive transfusion protocol in management of life-
threatening should depend on each obstetric unit. 
Keywords: blood transfusion, obstetric cases, patient blood 
management.
Abstrak
Tujuan: Untuk mendiskusikan tentang hilang darah 
dalam obstetrik, peran transfusi darah, dan patient blood 
management.
Metode: Kajian pustaka.
Hasil: Anemia berat dengan nilai hemoglobin kurang dari 7 
g/dL atau kehamilan lanjut (lebih dari 34 minggu) dan/atau 
gejala nyata anemia, rekomendasi ialah memberikan satu 
unit transfusi diikuti dengan penilainan klinis untuk transfusi 
lebih lanjut. Pada perdarahan postpartum, protokol transfusi 
masif umum digambarkan sebagai volume darah yang 
dibutuhkan jumlah banyak dalam periode singkat, transfusi 
lebih dari 10 sel darah merah dalam 24 jam atau lebih dari 1 
jam, penggantian lebih dari 50% total volume darah dalam 3 
jam. Seluruh unit obstetrik memiliki protokol transfusi masif 
yang jelas untuk tata laksana awal perdarahan postpartum 
dengan mempertimbangkan transfusi awal untuk komponen 
sel darah merah dan FFP.
Kesimpulan: Patient blood management bertujuan untuk 
menjaga konsentrasi hemoglobin, optimalisasi hemostasis, 
dan minimalisasi hilang darah untuk meningkatkan luaran 
pasien. Protokol transfusi masif dalam tata laksana yang 
mengancam nyawa sangat bergantung pada setiap unit 
obstetrik.
Kata kunci: kasus obstetri,   patient blood management, 
transfusi darah.
INTRODUCTION
Obstetric hemorrhage is the leading cause 
of maternal mortality worldwide. World Health 
Organization (WHO) stated that >78,000 women 
(around 27% of all maternal death) were due 
to obstetric hemorrhage in 2013.1 Apart from 
mortality, obstetric hemorrhage impacts to 
women's health. Survey from WHO found 
that 1.2% of women experienced postpartum 
hemorrhage with 17.6% of those resulting in 
severe maternal outcomes such as "near miss" of 
resultant organ dysfunction.2 The US Centers for 
Disease Control (CDC) stated that severe maternal 
morbidity includes ICU admission or transfusion 
of 4 or more whole blood or packed RBC units.3 
This is refl ected in the need of quantitative 
blood loss required in every obstetric setting.4 
Meanwhile, blood transfusion is an important 
process as a temporary measure during anaemia. 
Blood transfusion replaces blood loss during 
procedures, injuries, and upkeep blood levels 
when the body fails to produce blood properly.5 
This issue raises the concern whether blood loss 
during obstetric cases can be replaced by blood 
transfusion. This article will discuss about blood 
loss in an obstetric setting, the role of blood 
transfusion, and patient blood management. 
Anaemia during Pregnancy
There are many signifi cant physiological 
changes that happen during pregnancy. 
Pregnancy increases plasma volume by 40 to 50 
percent in the 32nd week greater than red blood 
cell (RBC) mass which causes hemodilution. 
It causes physiological anaemia in pregnant 
mothers. Apart from that, iron metabolism also 
increases during the second and third trimester 
making women more prone to anaemia.6 A 
recommendation that full blood count should be 
obtained to scree for anaemia at fi rst antenatal 
visit and 28 weeks, as well as any time during 
pregnancy if symptoms of anaemia are present 
(1A). Anaemia in pregnancy does not always 
require transfusion, as they can be replaced 
with preventive or treatment-based nutritional 
support, adequate antenatal care, and risk factor 
management.7 
In severe anaemia with hemoglobin level 
less than 7 g/dL or late gestation (more than 34 
weeks) and/ or signifi cant symptoms of anaemia, 
the recommendation is to refer to secondary care 
clinic to make further investigation (1C). In the 
absence of bleeding, only single unit transfusion 
followed by clinical reassessment for further 
transfusion (1C).7
Postpartum Hemorrhage
Pregnancy  can  also  increase in 
hypercoagulation due to increase in procoagulant 
factors including von Willebrand factor (vWF), 
FVII, FVIII, FIX as well as decreased anticoagulant 
factors, such as protein S.8 This adaptation is to 
minimalize the risk of postpartum hemorrhage 
(PPH). American Society of Obstetrics and 
Gynecologists (ACOG) revitalize program defi nes 
that postpartum hemorrhage as cumulative blood 
loss more than 1,000 mL blood loss accompanied 
by signs or symptoms of hypovolemia within 24 
hours after birth process regardless the route of 
delivery. 9
Successful management of obstetric 
hemorrhage consists of investigation for 
underlying etiology, administering targeted 
therapies, and transfusion whether needed. 
Protocols for massive transfusion and 
emergency-released blood products are essential 
for maternity unit through collaboration with 
blood bank.10 Massive transfusion protocols are 
commonly used description as large volume of 
blood products over a brief period to a patient 
with uncontrolled or severe hemorrhage, 
transfusion more than 10 RBC units within 24 
hours, transfusion more than 4 RBC units in 1 
hour with anticipation of continued need for 
blood, replacement of more than 50% of total 
blood volume by blood products within 3 hours. 
ACOG recommends initial transfusion ratio for 
PRC: fresh frozen plasma (FFP): platelets of 1:1:1 
and it is similar with replacement of whole blood. 
Actually, more important than ratio is the specifi c 
protocol for multicomponent therapy in each 
institution. For example, women with suspected 
disseminated intravascular coagulation (in cases 
of placental abruption or amniotic fl uid embolism) 
should obtain cryoprecipitate.9 Meanwhile, Royal 
College of Obstetricians and Gynecologists 
(RCOG) stated no fi rm criteria for initiating 
red cell transfusion and the decision is given 
to clinical judgement. In an extreme situation 
or blood group is unknown, group O RhD-
negative red cells should be given with risk for 
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shock.15,16 In Network for the Advancement of 
Patient Blood Management, Hemostasis and 
Thrombosis (NATA) consensus, FFP transfusion 
with 15-20 ml/kg in severe ongoing PPH guided 
by abnormalities in coagulation test (such as PT, 
INR and/or APTT >1.5 times normal or clotting 
time prolongation).7 In unknown of laboratory 
results, NATA suggests administration of FPP 
transfusion at lest in 1:2 FFP:RBC ratio until result 
of hemostatic.17 A consensus stated that platelets 
with dose of 6-10 ml/kg should be transfused at 
platelet counts <75×109/L (or when point-of-
care testing indicates impaired platelet function), 
aiming to maintain a level >50×109/L during 
ongoing PPH.7 Meanwhile, NATA suggests 
all obstetric units have a clear-cut massive 
transfusion protocol for the initial management 
of life-threatening PPH, considering early 
transfusion therapy with RBCs and FFP.7
CONCLUSION
Transfusion in obstetric cases can be caused due 
to anaemia during pregnancy or postpartum 
hemorrhage. Patient blood management aims 
to maintain hemoglobin concentration, optimize 
hemostasis, and minimize blood loss in effort to 
improve patient outcomes. Massive transfusion 
protocol in the management of life-threatening 
should depend on each obstetric unit. 
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